16p13.11 microduplication syndrome

16p13.11 microduplication syndrome (Orphanet code 261243) is a rare chromosomal anomaly characterized by a duplication of a small segment of the short arm of chromosome 16 at the 13.11 band. This copy number variant is associated with a broad and variable clinical presentation, and notably, the duplication can also be found in apparently unaffected individuals, making its clinical interpretation complex. The duplicated region contains several genes, including NDE1 and MYH11, which are thought to contribute to the neurodevelopmental features observed in some carriers. The syndrome primarily affects the central nervous system and neurodevelopmental functioning. Key clinical features may include intellectual disability (often mild), learning difficulties, speech and language delays, autism spectrum disorder, attention deficit hyperactivity disorder (ADHD), and behavioral problems. Some individuals may also present with seizures or epilepsy. Congenital anomalies, including cardiac defects and skeletal abnormalities, have been reported in some cases but are not consistently present. The phenotype is highly variable, even among affected members of the same family, ranging from significant developmental challenges to no apparent clinical manifestation. There is currently no specific or curative treatment for 16p13.11 microduplication syndrome. Management is supportive and symptom-based, typically involving early intervention programs, speech therapy, occupational therapy, behavioral therapy, and educational support tailored to the individual's needs. Seizures, if present, are managed with standard antiepileptic medications. Cardiac or other structural anomalies are addressed through standard medical or surgical approaches. Genetic counseling is recommended for affected individuals and their families to discuss the variable expressivity and incomplete penetrance associated with this duplication.

Common questions about 16p13.11 microduplication syndrome